Comparing Physiological Ventricular Pacing and Managed Ventricular Pacing to Prevent Persistent Atrial Fibrillation in Patients with Prolonged Atrioventricular Interval
Led by Quovadis Associazione · Updated on 2025-05-11
640
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the superiority of physiological ventricular pacing compared to managed ventricular pacing for preventing persistent atrial fibrillation in patients who have a prolonged atrioventricular interval and require pacing due to sinus node disease or certain types of second-degree atrioventricular block. This multicenter, prospective, randomized trial uses CE-marked devices already in clinical practice to compare these pacing methods.
The study involves two groups one receiving physiological ventricular pacing PhysioVP, which delivers stimulation to the hearts natural conduction system to correct the PR interval and avoid dyssynchrony, and the other receiving managed ventricular pacing DDD-VPA, which uses right ventricular leads and algorithms to minimize ventricular pacing. Both groups receive atrial leads placed in the right atrial appendage. Patients are implanted with dual-chamber pacemakers and monitored over time.
Participants will have in-office clinical checks at 1, 12, 24, and 36 months after implantation, with additional home monitoring at 6, 18, and 30 months. Researchers will measure outcomes such as the occurrence of persistent atrial fibrillation and clinical composite outcomes over 36 months. Secondary measures include heart function, remodeling, and safety endpoints. The study continues monitoring for three years to evaluate the pacing methods impact.
CONDITIONS
Brief Title
Physiological Ventricular Pacing Vs Managed Ventricular Pacing for Persistent AF Prevention in Prolonged AV Interval
Research Team
G
Gianni Pastore, MD
F
Franco Noventa, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Indication for pacemaker implantation due to sinus node disease
Indication for pacemaker implantation due to paroxysmal type 1 or 2 second-degree AV block
You will not qualify if you...
Candidates for implantable cardioverter-defibrillator or cardiac resynchronization therapy device implantation
Severe mitral or aortic valve regurgitation or stenosis
Previous atrial fibrillation ablation involving left pulmonary veins
Cardiac surgery within 3 months before pacemaker implantation
History of long-standing persistent atrial fibrillation
Permanent third-degree atrioventricular block
Participation in another clinical trial within the past 3 months
Pregnancy or intention to become pregnant
Life expectancy less than 3 years
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Implementation
Duration - 1 day
Participants undergo implantation of pacing devices with either physiological ventricular pacing leads or managed ventricular pacing leads placed in the heart.
1 implantation visit (in-person)
Post-implantation Monitoring
Duration - 36 months
Participants are monitored through clinical visits and home monitoring to assess the effectiveness and safety of the pacing devices in preventing persistent atrial fibrillation.
In-office visits at 1, 12, 24, and 36 months and home monitoring at 6, 18, and 30 months
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Study of BIOTRONIK Dual-Chamber Pacemakers Using Left Bundle Branch Area Pacing and Closed Loop Stimulation
Observing Heart Rhythm and Atrial Fibrillation in Patients with Sinus Node Disease and AV Block
Comparing Physiological Ventricular Pacing and Managed Ventricular Pacing to Prevent Persistent Atrial Fibrillation in Patients with Prolonged Atrioventricular Interval
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The PhysioVP-AF study, a randomized controlled trial to assess the clinical benefit of physiological ventricular pacing vs. managed ventricular pacing for persistent atrial fibrillation prevention in patients with prolonged atrioventricular conduction: design and rationale.